Higher Cardiovascular Health Reduced Risk of Gout
HCPLive
SEPTEMBER 26, 2024
Higher Life’s Essential 8 score was associated with higher CVH scores in US adults.
HCPLive
SEPTEMBER 26, 2024
Higher Life’s Essential 8 score was associated with higher CVH scores in US adults.
Med Page Today
SEPTEMBER 26, 2024
(MedPage Today) -- Recent skin cancer risk stratification guidelines did not improve rates of timely dermatologic follow-up visits among solid organ transplant recipients, according to an analysis of claims data. The rate of post-transplant dermatology.
HCPLive
SEPTEMBER 26, 2024
Physicians who received pharmaceutical industry payments related to 4 different direct-acting antivirals were more likely to prescribe these medications.
JAMA Cardiology
SEPTEMBER 26, 2024
This prespecified analysis of the Finerenone Trial to Investigate the Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF) randomized clinical trial investigates the long-term effects of treatment with the nonsteroidal mineralocorticoid receptor antagonist, finerenone, in patients with heart failure with mildly reduced or preserved ejection fraction.
Med Page Today
SEPTEMBER 26, 2024
(MedPage Today) -- Semaglutide (Ozempic, Wegovy) may help reduce the risk of an opioid overdose in certain people, an emulation target trial suggested. Over a 1-year follow-up, people with comorbid type 2 diabetes and opioid use disorder (OUD.
HCPLive
SEPTEMBER 26, 2024
Lack of retinopathy, lower hemoglobin A1c levels, preserved eGFR, microalbuminuria, and lower UPCR were linked to non-DKD.
Stroke Journal
SEPTEMBER 26, 2024
Stroke, Ahead of Print.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
American College of Cardiology
SEPTEMBER 26, 2024
Does semaglutide efficacy vary with baseline diuretic use and does semaglutide change diuretic dose in patients with heart failure with preserved ejection fraction (HFpEF)?
HCPLive
SEPTEMBER 26, 2024
The FDA approves Cobenfy, the first pharmacological approach to treating schizophrenia since the 1970s.
ADN Center of Excellence
SEPTEMBER 26, 2024
In our ongoing commitment to advancing cardiovascular care, ADN CoE recently hosted an intensive Transcatheter Aortic Valve Implantation (TAVI) Training at the prestigious Adana City Health Training and Research Center. This event, led by the renowned Prof. Dr. Halil Ibrahim Kurt, offered an unparalleled opportunity for cardiologists to enhance their skills in this cutting-edge procedure.
HCPLive
SEPTEMBER 26, 2024
Younger people and people without European origin were less likely to adhere to urate-lowering therapy.
Becker's Hospital Review - Cardiology
SEPTEMBER 26, 2024
Hospitals with higher guideline-directed medical therapy scores showed lower rates of mortality, rehospitalization and costs in heart failure patients, according to a Sept. 25 study released by JAMA Cardiology.
HCPLive
SEPTEMBER 26, 2024
Temtokibart showed similar efficacy to dupilumab in treating moderate-to-severe atopic dermatitis, with faster skin hydration improvements in a phase 2a trial.
American College of Cardiology
SEPTEMBER 26, 2024
What are the effects of the current therapeutic options for chronic thromboembolic pulmonary hypertension (CTEPH) in a worldwide context?
HCPLive
SEPTEMBER 26, 2024
This interview with Alexis features his reaction to the approval of lebrikizumab for eczema and its significance.
American College of Cardiology
SEPTEMBER 26, 2024
In this prespecified analysis of the DIAMOND trial, what is the effect of patiromer in patients with heart failure with reduced ejection fraction (HFrEF) when examining the current and past hyperkalemia subgroups?
HCPLive
SEPTEMBER 26, 2024
Elias discusses the challenges of prosthetic valve evaluation, highlighting the role of sonographers, Doppler imaging, and the importance of ongoing training.
American College of Cardiology
SEPTEMBER 26, 2024
The accumulation of micro-nanoplastics (MNPs) in the body may lead to adverse cardiovascular effects and may represent a novel risk factor for cardiovascular disease, according to a state-of-the-art review published in the European Heart Journal.
HCPLive
SEPTEMBER 26, 2024
The DELTA trial results on delgocitinib cream as a topical option for CHE were presented at the EADV Congress 2024.
ADN Center of Excellence
SEPTEMBER 26, 2024
In our ongoing commitment to advancing cardiovascular care, ADN CoE recently hosted an intensive Transcatheter Aortic Valve Implantation (TAVI) Training at the prestigious Adana City Health Training and Research Center. This event, led by the renowned Prof. Dr. Halil Ibrahim Kurt, offered an unparalleled opportunity for cardiologists to enhance their skills in this cutting-edge procedure.
CTVS
SEPTEMBER 26, 2024
An aortic aneurysm is a very serious condition that occurs when the aorta (the largest artery in the body that comes off the heart) develops a bulb-like formation. If the aneurysm is not treated appropriately, it can rupture or lead to an aortic dissection, causing blood to dangerously leak out of the aorta and prove life-threatening.
HCPLive
SEPTEMBER 26, 2024
Panelists discuss how the findings from the ORAL Surveillance study regarding cardiovascular and cancer risks associated with tofacitinib have influenced perceptions of JAK inhibitors, emphasizing the need to balance safety concerns with their efficacy in managing rheumatoid arthritis.
The American Journal of Cardiology
SEPTEMBER 26, 2024
Publication date: Available online 26 September 2024 Source: The American Journal of Cardiology Author(s): Eduard Ródenas-Alesina, Jordi Lozano-Torres, Pablo Eduardo Tobías-Castillo, Clara Badia-Molins, Maria Calvo-Barceló, Rosa Vila-Olives, Guillem Casas-Masnou, Aleix Olivella San Emeterio, Toni Soriano-Colomé, Rubén Fernández-Galera, Ana B Méndez-Fernández, José A Barrabés, José Rodríguez-Palomares, Ignacio Ferreira-González
HCPLive
SEPTEMBER 26, 2024
Panelists discuss how their approaches to treating patients with rheumatoid arthritis focus on personalized strategies that prioritize achieving remission while carefully monitoring safety and efficacy outcomes.
Coronary Artery Disease Journal
SEPTEMBER 26, 2024
No abstract available
HCPLive
SEPTEMBER 26, 2024
These new data on treatment of atopic dermatitis and prurigo nodularis were presented by Galderma at the European Academy of Dermatology & Venereology Congress.
HeartRhythm
SEPTEMBER 26, 2024
Epicardial adipose tissue (EAT) is closely associated with atrial fibrillation (AF), suggesting it may be one of the causes of AF progression. However, it is unclear whether atrial fibrillation affects EAT.
Journal of Cardiovascular Electrophysiology
SEPTEMBER 26, 2024
The positive F wave in lead V1 changed during entrainment from the right atrial appendage (RAA) during typical atrial flutter (AFL). The 3-dimensional (3D) electroanatomical map during entrainment from the RAA revealed an area of antidromic capture around the RAA, which was the only difference from the 3D electroanatomical map of typical AFL, proving that the activation around the RAA is responsible for the generation of the positive F wave in lead V1 of typical AFL.
HCPLive
SEPTEMBER 26, 2024
A randomized trial suggests gefarnate significantly reduces triglycerides and LDL-C in older adults on statins with residual hypertriglyceridemia.
American College of Cardiology
SEPTEMBER 26, 2024
A culturally adapted group-based lifestyle intervention targeted towards South Asian participants did not lead to a substantial difference in improving risk factors at one year compared with written health education materials.
Circulation: Arrhythmia and Electrophysiology
SEPTEMBER 26, 2024
Circulation: Arrhythmia and Electrophysiology, Ahead of Print.
The American Journal of Cardiology
SEPTEMBER 26, 2024
Publication date: Available online 25 September 2024 Source: The American Journal of Cardiology Author(s): Talhat Azemi, Fahad Ahmed, Immad Sadiq, William Lane Duvall, Sean McMahon, Jeff F. Mather, Sabet W. Hashim, Raymond G.
Let's personalize your content